38.73
前日終値:
$38.96
開ける:
$39.29
24時間の取引高:
1.87M
Relative Volume:
0.76
時価総額:
$7.29B
収益:
$550.17M
当期純損益:
$201.35M
株価収益率:
38.73
EPS:
1
ネットキャッシュフロー:
$232.07M
1週間 パフォーマンス:
-2.81%
1か月 パフォーマンス:
-11.35%
6か月 パフォーマンス:
-36.51%
1年 パフォーマンス:
-32.21%
Doximity Inc Stock (DOCS) Company Profile
名前
Doximity Inc
セクター
電話
(650) 549-4330
住所
500 THIRD STREET, SUITE 510, SAN FRANCISCO
DOCS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
DOCS
Doximity Inc
|
38.73 | 7.34B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
217.99 | 35.81B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
64.57 | 11.89B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
39.55 | 7.04B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
82.85 | 7.09B | 1.15B | 96.70M | -161.99M | 1.09 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-20 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | 開始されました | RBC Capital Mkts | Outperform |
| 2026-01-08 | アップグレード | Truist | Hold → Buy |
| 2025-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-11-21 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | 開始されました | BMO Capital Markets | Market Perform |
| 2025-10-27 | アップグレード | BofA Securities | Neutral → Buy |
| 2025-10-10 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2025-10-01 | ダウングレード | Goldman | Neutral → Sell |
| 2025-07-09 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-06-02 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-02-07 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 開始されました | Stephens | Equal-Weight |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-11-15 | 開始されました | Goldman | Neutral |
| 2024-11-14 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | アップグレード | Barclays | Equal Weight → Overweight |
| 2024-08-09 | アップグレード | Needham | Hold → Buy |
| 2024-07-18 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | アップグレード | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 開始されました | Leerink Partners | Market Perform |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2024-01-02 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-08-09 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-08-09 | ダウングレード | Needham | Buy → Hold |
| 2023-08-03 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 開始されました | Wells Fargo | Overweight |
| 2022-10-24 | 開始されました | Evercore ISI | In-line |
| 2022-10-13 | 開始されました | BTIG Research | Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-08-05 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 開始されました | Berenberg | Buy |
| 2022-05-18 | 繰り返されました | BofA Securities | Neutral |
| 2022-05-18 | 繰り返されました | Goldman | Buy |
| 2022-05-18 | 繰り返されました | Guggenheim | Buy |
| 2022-05-18 | 繰り返されました | Jefferies | Buy |
| 2022-05-18 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 繰り返されました | Needham | Buy |
| 2022-04-07 | 開始されました | Guggenheim | Buy |
| 2022-04-04 | 開始されました | BofA Securities | Neutral |
| 2022-02-11 | 開始されました | Goldman | Buy |
| 2021-12-14 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 開始されました | Jefferies | Buy |
| 2021-11-17 | 開始されました | Robert W. Baird | Outperform |
| 2021-11-10 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-11-10 | 繰り返されました | Goldman | Neutral |
| 2021-11-10 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 繰り返されました | Needham | Buy |
| 2021-11-10 | 繰り返されました | Piper Sandler | Overweight |
| 2021-08-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 開始されました | Canaccord Genuity | Buy |
| 2021-07-19 | 開始されました | Goldman | Neutral |
| 2021-07-19 | 開始されました | JP Morgan | Overweight |
| 2021-07-19 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 開始されました | Piper Sandler | Overweight |
| 2021-07-19 | 開始されました | Raymond James | Outperform |
| 2021-07-19 | 開始されました | SVB Leerink | Outperform |
| 2021-07-19 | 開始されました | William Blair | Outperform |
すべてを表示
Doximity Inc (DOCS) 最新ニュース
Is It Time To Reassess Doximity (DOCS) After Its Recent Share Price Slide? - Yahoo Finance
Is Doximity (DOCS) Trading Medicare Resilience For A Slower, Narrower Platform Growth Story? - Yahoo Finance
Doximity stock hits 52-week low at $38.75 amid challenging year - Investing.com Nigeria
Doximity (NYSE:DOCS) Upgraded at Zacks Research - MarketBeat
Doximity (DOCS) Stock Dips While Market Gains: Key Facts - Yahoo Finance Singapore
Are Telehealth Stocks Set to Tumble in 2026? - The Globe and Mail
What Makes Doximity (DOCS) a New Strong Buy Stock - Yahoo Finance
Doximity (DOCS) Fell as Guidance Fell Short of Expectations - Insider Monkey
Assessing Doximity (DOCS) Valuation After Cautious Earnings Guidance And Guarded Investor Sentiment - Yahoo Finance
Baillie Gifford & Co. Reduces Stock Position in Doximity, Inc. $DOCS - MarketBeat
OpenEvidence, Doximity Advance Dispute Over AI Platform Access - Bloomberg Law News
Insider Trends: What is the cash position of Doximity IncTrade Risk Report & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Overweight Doximity (DOCS) Position Weighs on Fund Performance - Insider Monkey
Zacks Industry Outlook Highlights Doximity, 10x Genomics and Omnicell - Yahoo Finance
Aubrey Capital Management Ltd Purchases Shares of 62,500 Doximity, Inc. $DOCS - MarketBeat
Doximity (NASDAQ:DOCS) Hits New 12-Month LowHere's What Happened - MarketBeat
Doximity stock hits 52-week low at $39.92 amid challenging year - Investing.com Nigeria
Doximity stock hits 52-week low at $39.92 amid challenging year By Investing.com - Investing.com India
Wells Fargo & Company Upgrades Doximity (NYSE:DOCS) to Strong-Buy - MarketBeat
Doximity (NASDAQ:DOCS) Strengthens Professional Medical Networking - Kalkine Media
DOCS Analyst Rating Update: Wells Fargo Lowers Price Target | DO - GuruFocus
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino’s Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - AOL.com
Assessing Doximity: Insights From 9 Financial Analysts - Benzinga
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino's Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - 24/7 Wall St.
Morgan Stanley views Doximity (DOCS) underperformance as attractive entry point amid strong engagement - MSN
Is It Time To Reconsider Doximity (DOCS) After Recent Share Price Weakness - Sahm
Doximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026 - 01net
Raymond James Sees 'Knee-Jerk' AI Reaction, Reaffirms Strong Buy on Doximity, Inc. (DOCS) - Finviz
Doximity (DOCS) Is Down 13.4% After Cutting 2026 Revenue Outlook Amid Regulatory PressuresWhat's Changed - Sahm
Raymond James Sees ‘Knee-Jerk’ AI Reaction, Reaffirms Strong Buy on Doximity, Inc. (DOCS) - Insider Monkey
Raymond James sees ‘knee-jerk’ AI reaction, reaffirms strong buy on Doximity, Inc. (DOCS) - MSN
Bandwidth, Dynatrace, Paylocity, Doximity, and Agilysys Stocks Trade Down, What You Need To Know - The Globe and Mail
RSI Alert: Doximity (DOCS) Now Oversold - Nasdaq
Redlands Daily Facts - FinancialContent
Is Doximity (DOCS) Pricing Reflect Its Mixed Valuation Signals After Recent Share Price Slide - Yahoo Finance
Doximity (DOCS) Declines More Than Market: Some Information for Investors - sharewise.com
Doximity (DOCS) declines more than market: Some information for investors - MSN
Winners Losers: Will Doximity Inc stock reach Wall Street targetsJuly 2025 Intraday Action & Risk Controlled Daily Trade Plans - Bộ Nội Vụ
Here's Why Doximity (DOCS) is a Strong Growth Stock - sharewise.com
Doximity (NASDAQ:DOCS) Sets New 1-Year LowWhat's Next? - MarketBeat
Here Are Monday’s Top Wall Street Analyst Research Calls: Doximity, KB Home, NVIDIA, Okta, On Holdings, Take-Two Interactive, Vail Resorts, and More - AOL.com
Ad Vital Founder Dr. Shitel Patel Featured in Doximity For Expertise on Practice Sustainability - Digital Journal
Penticton Herald: FinanceDoximity (DOCS) Shares Hit 52-Week Low: Analyzing the Digital Health Downturn - FinancialContent
Doximity stock hits 52-week low at 43.17 USD By Investing.com - Investing.com Nigeria
Doximity stock hits 52-week low at 43.17 USD - Investing.com
Doximity (DOCS) Slid on Renewed Volatility - Yahoo Finance
As layoff loomed, exec turned to insider trading - Investment Executive
Volatility Watch: Will Doximity Inc stock benefit from upcoming earnings reportsOptions Play & Safe Entry Trade Reports - Bộ Nội Vụ
Doximity to settle securities litigation lawsuit for $31M - MSN
InvestingPro’s Fair Value model predicted Doximity’s 41% stock decline By Investing.com - Investing.com UK
Doximity Inc (DOCS) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):